Publications by authors named "John Arrowsmith"

Claim this Profile
A
An analysis of the attrition of drug candidates from four major pharmaceutical companies.
Michael J Waring, John Arrowsmith, Andrew R Leach, Paul D Leeson, Sam Mandrell

Nat Rev Drug Discov· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial watch: phase II and phase III attrition rates 2011-2012.
John Arrowsmith, Philip Miller

Nat Rev Drug Discov· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orphan drug development: an economically viable strategy for biopharma R&D.
Kiran N Meekings, Cory S M Williams, John E Arrowsmith

Drug Discov Today· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival.
Paul Morgan, Piet H Van Der Graaf, John Arrowsmith, Doug E Feltner, Kira S Drummond

Drug Discov Today· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A decade of change.
John Arrowsmith

Nat Rev Drug Discov· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial watch: Phase II failures: 2008-2010.
John Arrowsmith

Nat Rev Drug Discov· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial watch: phase III and submission failures: 2007-2010.
John Arrowsmith

Nat Rev Drug Discov· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis